Community Health Systems, Inc. reports developments for a U.S. hospital operator whose subsidiaries own or lease affiliated hospitals and operate outpatient sites of care, including physician practices, urgent care centers, freestanding emergency departments, imaging centers, cancer centers and ambulatory surgery centers. Its news commonly covers financial and operating results, hospital and outpatient portfolio changes, ambulatory surgery center growth, community health initiatives and capital-structure actions involving senior secured notes.
Recurring updates also include debt tender offers and redemptions through CHS/Community Health Systems, Inc., divestitures of hospital assets, conference-call announcements and other material events affecting the company's healthcare delivery network.
Community Health Systems (NYSE: CYH) reported an $86 million third-quarter 2026 loss attributable to stockholders, reversing a year-earlier profit. The diluted loss was $0.63 per share, versus earnings of $0.96. Revenue fell 10.7% to $2.757 billion, while same-store revenue rose 3.8%. Adjusted EBITDA, a non-GAAP earnings measure, declined to $280 million from $376 million. Operating cash flow increased to $155 million from $70 million.
Same-store admissions rose 2.2%, but total admissions fell 12.3%. For the nine months ended September 30, revenue declined 8.9% to $8.547 billion; the stockholder loss was $74 million versus income of $399 million. Operating activities used $55 million versus providing $277 million. Through October 28, the company completed sales of its 80% interest in one hospital and nine other hospitals. Management said payor mix and patient acuity hurt quarterly results and expectations for the remainder of 2026.
Community Health Systems (NYSE: CYH) will webcast its third-quarter 2026 conference call on October 29, 2026, to review financial and operating results. Results for the quarter ended September 30, 2026, will be released on October 28 after the regular close of trading. The call begins at 10:00 a.m. Central Time, 11:00 a.m. Eastern Time. An online replay will remain available for approximately 30 days after the call.
Community Health Systems (CYH) released its 2026 Community Impact Report, summarizing operational, clinical, workforce, and community contributions for the year ended 12/31/2025.
The report notes more than 12.1 million total patient encounters and $4.4 billion in charity care, uninsured discounts, and other uncompensated services. Economic impact included $5.4 billion in payroll and benefits and $443 million in income, property, sales, and other taxes paid. CHS invested $398 million to expand access to care, enhance service lines, modernize facilities, and upgrade clinical technologies.
Patient safety initiatives introduced in 2022 have reduced sepsis mortality by more than 50% and prevented over 900 hospital-acquired infections. Since 2022, the Pathways Program has provided more than $90 million in student loan repayments and tuition assistance to employees. The report also highlights community initiatives such as collecting over 200,000 jars of peanut butter for local food banks in 2026.
Community Health Systems (CYH) will participate in the Wells Fargo 21st Annual Healthcare Conference, held September 8-10, 2026. The company plans a fireside chat on Wednesday, September 9, 2026, at 4:30 p.m. ET (3:30 p.m. CT). The presentation will be accessible to investors via a live audio webcast, with both the live stream and replay available through a link in the investor relations section of the company’s website, www.chs.net.
Community Health Systems (NYSE: CYH) reported second-quarter 2026 net operating revenues of $2.825 billion, down 9.8% from $3.133 billion in 2025, while same-store revenues rose 2.4%. Net income attributable to stockholders was $70 million, or $0.51 diluted EPS, versus $282 million, or $2.09, a year earlier. Excluding specified adjusting items, diluted EPS reflected a net loss of $(0.19) versus $(0.05) in 2025. Adjusted EBITDA declined to $330 million from $380 million, with performance affected by divestitures, payor mix and higher specialist fees, partially offset by higher volumes, reimbursement rates and lower contract labor. Cash from operations was $87 million, flat year over year. The company used about $600 million of divestiture proceeds to repurchase $368 million of 4.750% 2031 notes and $231 million of 10.875% 2032 notes via a tender offer.
Community Health Systems (NYSE: CYH) will host a webcast and conference call to review its second quarter 2026 financial and operating results. The earnings release will be issued after market close on July 22, 2026, with the call on July 23, 2026.
Freeman Health System has completed its acquisition of Northwest Health from a subsidiary of Community Health Systems (NYSE: CYH), expanding its network into Northwest Arkansas. The deal adds four medical centers, associated outpatient sites, physician practices, and about 2,200 employees to Freeman’s regional care footprint.
Northwest Health facilities will keep current providers and accepted insurance plans. Long-term goals include expanding behavioral health, maternal care, and specialty services such as cardiology, oncology, and orthopedics across the fast-growing Northwest Arkansas market.
Community Health Systems (NYSE: CYH) completed the sale of four Arkansas hospitals and related outpatient centers and practices to Freeman Health System for $110 million before transaction expenses.
The divested facilities total 487 licensed beds. The definitive agreement was signed on March 5, 2026, and closing occurred on June 1, 2026.
Community Health Systems (NYSE:CYH) announced that management will take part in the 2026 RBC Capital Markets Global Healthcare Conference in New York on May 19-20, 2026.
The company will host a fireside chat on May 20, 2026, at 9 a.m. ET, available to investors via live audio webcast and replay on its investor relations website.
Community Health Systems (NYSE: CYH) announced early tender results for a cash tender offer by its subsidiary to buy up to $600,000,000 aggregate principal of its 4.750% 2031 notes and 10.875% 2032 notes. Proration factors are ~37.07% for 2031 and ~28.14% for 2032, with accepted principal of $368,421,000 (2031) and $230,946,000 (2032). The Issuer expects an Early Settlement Date of May 7, 2026. No post-early tenders will be accepted unless the Issuer amends the offer.